Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV-Reference-Cited by-同舟云学术

Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV

Published:2024-05-22 Issue:7 Volume:13 Page:1391-1398
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Vannappagari Vani^ORCID,McCallister Scott,Romach Beth,Bush Mark,Stanislaus Dinesh,Root Charlotte,Lampkin Christine,Nwokolo Nneka,Puga Ana,Moreira Sebastian,Salem Farzaneh,DeMasi Ralph,Payvandi Nassrin,Smith Kimberly,Garges Harmony,de Ruiter Annemiek

Funder

ViiV Healthcare

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-00993-4.pdf

Reference17 articles.

1. UNICEF. Elimination of mother-to-child transmission. https://data.unicef.org/topic/hivaids/emtct/. Accessed 17 Apr 2024.

2. Office of AIDS Research, National Institutes of Health. HIV prevention: preventing perinatal transmission of HIV. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-transmission-hiv. Accessed 25 Jul 2023.

3. National Institutes of Health Grants and Funding. Vulnerable and other populations requiring additional protections. https://grants.nih.gov/policy/humansubjects/policies-and-regulations/vulnerable-populations.htm#Pregnant. Accessed 13 Feb 2023.

4. US Department of Health and Human Services Office for Human Research Protections. Subpart B – additional protections for pregnant women, human fetuses and neonates involved in research. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/common-rule-subpart-b/index.html#46.201. Accessed 25 Jul 2023.

5. Kappel D, Sahin L, Yao L, Thor S, Kweder S. A comparison of FDA and EMA pregnancy and lactation labeling. Clin Pharmacol Ther. 2023;13(6):1251–7.